Open AccessScreening for Hepatitis C Virus Infection in Adolescents and Adults
Author(s) -
US Preventive Services Task Force,
Douglas K Owens,
Karina W. Davidson,
Alex H. Krist,
Michael J. Barry,
Michael D. Cabana,
Aaron B. Caughey,
Katrina E Donahue,
Chyke A. Doubeni,
John W. Epling,
Martha Kubik,
Gbenga Ogedegbe,
Lori Pbert,
Michael Silverstein,
Melissa A. Simon,
ChienWen Tseng,
John B. Wong
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.1123
Subject(s) - medicine , asymptomatic , hepatitis c virus , hepatitis c , population , disease , pediatrics , immunology , virus , environmental health
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom